Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Argus Health
Merck
Cerilliant
Fuji
Dow
Accenture
Colorcon
Baxter
AstraZeneca

Generated: August 21, 2017

DrugPatentWatch Database Preview

EXTRA-STRENGTH AIM Drug Profile

« Back to Dashboard

What is the patent landscape for Extra-strength Aim, and when can generic versions of Extra-strength Aim launch?

Extra-strength Aim is a drug marketed by Chesebrough Ponds and is included in one NDA.

The generic ingredient in EXTRA-STRENGTH AIM is sodium monofluorophosphate. There are one thousand three hundred and ninety-two drug master file entries for this compound. Additional details are available on the sodium monofluorophosphate profile page.

Summary for Tradename: EXTRA-STRENGTH AIM

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list41
Clinical Trials: see list11,010
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EXTRA-STRENGTH AIM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chesebrough Ponds
EXTRA-STRENGTH AIM
sodium monofluorophosphate
GEL;DENTAL019518-002Aug 6, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Chesebrough Ponds
EXTRA-STRENGTH AIM
sodium monofluorophosphate
PASTE;DENTAL019518-001Jun 3, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Federal Trade Commission
Julphar
Deloitte
Harvard Business School
Fuji
Boehringer Ingelheim
QuintilesIMS
Novartis
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot